TABLE OF CONTENTS
Volume 154, Issue 2 (May 2008)
View table of contents by subject categoryFocused issue: Neuropharmacology of Addiction
- Focused issue:
- May 2008 Volume 154, No 2
In 2007, there were over 8,000 publications listed on PubMed that were keyed with either addiction OR substance abuse OR alcoholism. Clearly, this reflects substantial research effort in this area. Accordingly, the Special Issue series of the British Journal of Pharmacology has allocated a volume to allow us to explore the neuropharmacology of addiction with an emphasis on the identification of potential novel therapeutic strategies. With growing public awareness of the problems (both social and medical) associated with issues such as binge drinking, this is a timely release.
Specifically, this issue which is guest edited by Andrew Lawrence, Philip Beart & Peter Kalivas contains 11 reviews and 2 original articles that encompass a broad range of aspects pertinent to substance abuse and addiction.
Commentary
Commentary
Neuropharmacology of addiction—setting the scene FREE
A J Lawrence, P M Beart and P W Kalivas
Br J Pharmacol 154: 259-260; advance online publication, April 14, 2008; doi:10.1038/bjp.2008.131
See also: Review by Mayfield et al. See also: Review by McGregor et al. See also: Review by Nutt & Lingford-HughesSee also: Review by Thomas et al. See also: Review by Vengeliene et al.Focused Reviews
Review Article
The neurocircuitry of addiction: an overview
M W Feltenstein and R E See
Br J Pharmacol 154: 261-274; advance online publication, March 3, 2008; doi:10.1038/bjp.2008.51
Genetic factors influencing alcohol dependence
R D Mayfield, R A Harris and M A Schuckit
Br J Pharmacol 154: 275-287; advance online publication, March 24, 2008; doi:10.1038/bjp.2008.88
See also: Commentary by Lawrence et al.Physiology and pharmacology of alcohol: the imidazobenzodiazepine alcohol antagonist site on subtypes of GABAA receptors as an opportunity for drug development?
M Wallner and R W Olsen
Br J Pharmacol 154: 288-298; advance online publication, February 18, 2008; doi:10.1038/bjp.2008.32
Neuropharmacology of alcohol addiction
V Vengeliene, A Bilbao, A Molander and R Spanagel
Br J Pharmacol 154: 299-315; advance online publication, March 3, 2008; doi:10.1038/bjp.2008.30
See also: Commentary by Lawrence et al.Inhalant abuse among adolescents: neurobiological considerations FREE
D I Lubman, M Yücel and A J Lawrence
Br J Pharmacol 154: 316-326; advance online publication, March 10, 2008; doi:10.1038/bjp.2008.76
Neuroplasticity in the mesolimbic dopamine system and cocaine addiction
M J Thomas, P W Kalivas and Y Shaham
Br J Pharmacol 154: 327-342; advance online publication, March 17, 2008; doi:10.1038/bjp.2008.77
See also: Commentary by Lawrence et al.A neuropeptide-centric view of psychostimulant addiction FREE
B Boutrel
Br J Pharmacol 154: 343-357; advance online publication, April 14, 2008; doi:10.1038/bjp.2008.133
From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?
I S McGregor, P D Callaghan and G E Hunt
Br J Pharmacol 154: 358-368; doi:10.1038/bjp.2008.132
See also: Commentary by Lawrence et al.The endocannabinoid system in brain reward processes
M Solinas, S R Goldberg and D Piomelli
Br J Pharmacol 154: 369-383; advance online publication, April 14, 2008; doi:10.1038/bjp.2008.130
Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction
M J Christie
Br J Pharmacol 154: 384-396; advance online publication, April 14, 2008; doi:10.1038/bjp.2008.100
Addiction: the clinical interface
D Nutt and A Lingford-Hughes
Br J Pharmacol 154: 397-405; advance online publication, April 14, 2008; doi:10.1038/bjp.2008.101
See also: Commentary by Lawrence et al.Focused Research Papers
Neuropharmacology
Differential effects of the hypocretin 1 receptor antagonist SB 334867 on high-fat food self-administration and reinstatement of food seeking in rats
S G Nair, S A Golden and Y Shaham
Br J Pharmacol 154: 406-416; advance online publication, January 28, 2008; doi:10.1038/bjp.2008.3
Persistent downregulation of hippocampal CREB mRNA parallels a Y-maze deficit in adolescent rats following semi-chronic amphetamine administration
T Featherby, M van den Buuse, D I Lubman and A J Lawrence
Br J Pharmacol 154: 417-428; doi:10.1038/bjp.2008.126
Research Papers
Cardiovascular and pulmonary pharmacology
Inhibition of the rapid component of the delayed rectifier potassium current in ventricular myocytes by angiotensin II via the AT1 receptor
Y H Wang, C X Shi, F Dong, J W Sheng and Y F Xu
Br J Pharmacol 154: 429-439; advance online publication, April 14, 2008; doi:10.1038/bjp.2008.95
Drug Discovery
Discovery and biological characterization of a novel series of androgen receptor modulators
C Zhou, G Wu, Y Feng, Q Li, H Su, D E Mais, Y Zhu, N Li, Y Deng, D Yang and M-W Wang
Br J Pharmacol 154: 440-450; advance online publication, April 14, 2008; doi:10.1038/bjp.2008.107
Gastrointestinal pharmacology
Effects of imatinib mesylate on spontaneous electrical and mechanical activity in smooth muscle of the guinea-pig stomach
H Hashitani, M Hayase and H Suzuki
Br J Pharmacol 154: 451-459; advance online publication, April 14, 2008; doi:10.1038/bjp.2008.91
Immunopharmacology and inflammation
Treatment with DF 2162, a non-competitive allosteric inhibitor of CXCR1/2, diminishes neutrophil influx and inflammatory hypernociception in mice
T M Cunha, M M Barsante, A T Guerrero, W A Verri Jr, S H Ferreira, F M Coelho, R Bertini, C Di Giacinto, M Allegretti, F Q Cunha and M M Teixeira
Br J Pharmacol 154: 460-470; advance online publication, March 24, 2008; doi:10.1038/bjp.2008.94
Neuropharmacology
Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice
A Rizzi, R Vergura, G Marzola, C Ruzza, R Guerrini, S Salvadori, D Regoli and G Calo
Br J Pharmacol 154: 471-479; advance online publication, March 31, 2008; doi:10.1038/bjp.2008.96
